Brief introduction of Shuanghe pharmaceutical company

Brand-name products such as Aofosun and Synergistic Sulfonic Acid Tablets, which account for more than 50% of the national market, 1000 tons of chemical raw materials and more than 500 varieties 10 dosage forms; It has a national first-class pharmaceutical bioengineering industrial base that conforms to the characteristics of the capital's economic development; It has a product marketing network with 29 provincial capital cities as the core and radiating the surrounding areas; It has a production environment conforming to international GMP standards and advanced pharmaceutical equipment in the 1990s; Have a high-quality staff.

Since 1988, it has successively won the titles of "National May 1st Labor Medal", "National Advanced Enterprise in Pharmaceutical Industry" and "National Excellent Enterprise in Ideological and Political Work", and was listed as a pilot unit of modern enterprise system in Beijing 100.

1On August 28th, 1996, the company formally agreed to reorganize the main part of production and operation of Beijing Pharmaceutical Factory into a diversified joint stock limited company according to the Company Law of People's Republic of China (PRC). 19961996 February 16 Beijing Securities Regulatory Commission officially issued document No.27 [1996], Beijing Municipal People's Government Office1Beijing Securities Office Letter on March 2, 1997 (1.

As the first recommended stock (A-share) in Beijing in 1996, the company went public. Beijing Shuanghe Pharmaceutical Co., Ltd. (to be established) is a joint stock limited company established through social fundraising with the relevant assets and some monetary funds of injection branch, tablet branch, raw material medicine branch, preparation research institute and quality inspection department affiliated to Beijing Pharmaceutical Factory.